Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Goldman’s Facebook Fund: Why More Regulation Won’t Work

Goldman Sachs’ blatant attempt to circumvent securities law that divides private and public markets shows why more regulation in the US won’t work. The Securities and Exchange Commission is already incapable of enforcing current regulations, how could they possibly handle more responsibility?

Goldman Sachs Group Inc (NYSE:GS)

The securities law is crystal clear that when the shareholders of a private company exceed 500 “record holders”, the company has to register with the SEC. Goldman Sachs, acting as if they won’t be keeping records of the holders of Facebook shares, claim their Facebook fund is a single holder. If the SEC was even just a little bit credible, Goldman wouldn’t even think about raising this issue. What does the SEC do? They go after small peddlers who make a couple of thousands of dollars through some questionable form of insider trading. Remember the $22 K guy? When it comes to real players that the SEC is supposed to regulate, the SEC is publicly ridiculed by these too-big-to-fail (TBTF) market players who skirt regulations at every opportunity.

US capital markets don’t need more regulation. They need people who understand the true meaning of regulations and be brave enough to go after the big players who wreak havoc on the entire market.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!